Logo

Melvin Rubin, Pascal Goldschmidt

Oct 04, 2007
Premium
Opko Health said last month in a filing with the US Securities and Exchange Commission that Melvin Rubin has resigned as a member of its board.
 
The resignation did not arise from any disagreement with the company, Opko said.
 
This week, Opko said that Pascal Goldschmidt has joined its board, filling the vacancy left by Rubin.
 
Goldschmidt is currently senior vice president of medical affairs and dean of the University of Miami School of Medicine. He was previously chairman of the medicine department at Duke University Medical Center.
 
Goldschmidt holds an MD from Universite Libre de Bruxelles.

Filed under

Gene Silencing/Gene Editing
RNAi
Breaking News
The Scan

Gone, But Now Reconstructed SARS-CoV-2 Genomes

In a preprint, a researcher describes his recovery of viral sequences that had been removed from a common database.

Rare Heart Inflammation Warning

The Food and Drug Administration is adding a warning about links between a rare inflammatory heart condition and two SARS-CoV-2 vaccines, Reuters reports.

Sandwich Sampling

The New York Times sent tuna sandwiches for PCR analysis.

Nature Papers Describe Gut Viruses, New Format for Storing Quantitative Genomic Data, More

In Nature this week: catalog of DNA viruses of the human gut microbiome, new dense depth data dump format to store quantitative genomic data, and more.